Bought $CRCL at an average price of $65. The CLEAR Act is positive news. A rebound from the original family base. After the stock hit its lowest point, it coincided with so-called negative news at the bottom— but I don’t really see this as negative at all. Executives selling shares in U.S. stocks isn’t anything new, and personal buying cases are rarely seen; these are just noise.
This content is for informational and educational purposes only. It may include third-party insights, sponsored content, or promotional material for which the creator may receive compensation. Nothing in this feed constitutes investment advice or a guarantee of returns. You are solely responsible for your own investment decisions. Always conduct your own research and exercise caution before trading. We do not guarantee the accuracy of third-party information and are not liable for any losses incurred. Past performance is not indicative of future results. Please refer to our Community Terms and Risk Disclosure Statement for details.
Post your reply